- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia
Authors
Keywords
Acute lymphoblastic leukemia, Older adults, Elderly, Inotuzumab ozogamicin, Blinatumomab, Philadelphia chromosome
Journal
Current Hematologic Malignancy Reports
Volume 13, Issue 2, Pages 91-99
Publisher
Springer Nature
Online
2018-02-08
DOI
10.1007/s11899-018-0440-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
- (2018) Hagop Kantarjian et al. LANCET ONCOLOGY
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia
- (2016) Ashley E. Rosko et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2016) N. J. Short et al. BLOOD
- Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
- (2016) Philippe Rousselot et al. BLOOD
- Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation
- (2016) M Elsawy et al. BONE MARROW TRANSPLANTATION
- Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
- (2016) Hagop M. Kantarjian et al. CANCER
- Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease
- (2016) Ghayas C. Issa et al. CANCER
- Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis
- (2016) Koji Sasaki et al. CANCER
- Clinical impact ofABL1kinase domain mutations andIKZF1deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
- (2016) Rebecca DeBoer et al. LEUKEMIA & LYMPHOMA
- Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group
- (2016) Josep-Maria Ribera et al. LEUKEMIA RESEARCH
- Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients
- (2016) David J. Dorer et al. LEUKEMIA RESEARCH
- Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia
- (2016) Jessica T. Leonard et al. Science Translational Medicine
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults
- (2016) Craig Speziali et al. Current Hematologic Malignancy Reports
- Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
- (2015) D.-Y. Kim et al. BLOOD
- Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia
- (2015) Y. Chalandon et al. BLOOD
- Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
- (2015) Jordi Ribera et al. CANCER
- Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2015) Farhad Ravandi et al. CANCER
- BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- (2015) S. E. Alford et al. CANCER RESEARCH
- Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2015) N. Daver et al. HAEMATOLOGICA
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
- (2015) Elias Jabbour et al. LANCET ONCOLOGY
- Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2015) N. Daver et al. HAEMATOLOGICA
- Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia
- (2014) K. Beldjord et al. BLOOD
- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
- (2014) L. S. Muffly et al. HAEMATOLOGICA
- The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML)
- (2014) Kathleen Elliot et al. LEUKEMIA RESEARCH
- Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy
- (2013) F. Ravandi et al. BLOOD
- UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
- (2013) A. K. Fielding et al. BLOOD
- How I treat older patients with ALL
- (2013) N. Gokbuget BLOOD
- Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia
- (2013) Colombe Saillard et al. LEUKEMIA & LYMPHOMA
- Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial
- (2012) Jonathan I. Sive et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2011) R. Foa et al. BLOOD
- Polypharmacy in elderly patients with cancer: clinical implications and management
- (2011) Judith Lees et al. LANCET ONCOLOGY
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2010) M. Mohty et al. BLOOD
- A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
- (2010) M. Hunault-Berger et al. HAEMATOLOGICA
- Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993
- (2009) Adele K. Fielding et al. BLOOD
- A population-based cytogenetic study of adults with acute lymphoblastic leukemia
- (2009) A. V. Moorman et al. BLOOD
- Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia
- (2008) D. A. Thomas et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now